与Faricimab相关的无菌眼内炎症
Mariano Cozzi1,2, Alexander Ziegler1, Katrin Fasler1
1Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
JAMA ophthalmology
|October 10, 2024
概括
法里西马布静脉注射可能很少引起严重的眼内炎症,包括视网膜血管炎. 持续的患者监测对于早期发现和管理潜在的不良事件至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药物监督 药物监督 药物监督
背景情况:
- 随机临床试验评估药物的安全性和有效性.
- 现实世界的不良事件数据可以为罕见的安全问题产生假设.
研究的目的:
- 分析法里西马布治疗后眼内炎症的病例.
- 在临床实践环境中调查潜在的安全问题.
主要方法:
- 对接受法里西马布静脉注射的患者的观察病例系列综述.
- 对眼睛和系统史,多式成像和视觉敏度的分析.
- 评估炎症特征,眼内压力和事件发生时间.
主要成果:
- 七名患者 (12只眼睛) 在faricimab后发展出非感染性眼内炎症.
- 两个病例呈现了视网膜血管炎,一个是严重的视力丧失.
- 炎症发生在平均3.5次注射后,诊断是在最后一次注射后28天.
结论:
- 法里西马布治疗与罕见但可能严重的眼内炎症有关.
- 研究结果表明,需要对接受法里西马布的患者进行持续监测.
- 进一步的研究是有必要的,以了解因果关系和优化患者管理.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:27Open Angle Glaucoma: Treatment
401
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
401